Sign in

Research summary ·

Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review updates an earlier one on medical treatments for essential tremor. The first version came out in 2019. The team searched for trials that put people into groups by chance. Each trial had to follow people for at least 1 month. Each treatment was compared with a dummy treatment. The team then rated how strong the proof was.

What they found

The review looked at trials testing 16 treatments. Trial sizes ranged from 5 to 117 people. Trials lasted from 4 to 28 weeks. In more than one trial, tremor got less severe with propranolol. The same was seen with primidone, topiramate and botulinum toxin type A. Still, the team found serious flaws in how the trials were done. So the proof was too weak for every treatment studied.

What it means for patients

The authors say current trials cannot firmly show these treatments work. They call for longer trials of better quality. Such trials could help doctors and patients make treatment choices.

Why it is not certain yet

The authors point to a risk of bias in the trials. The results were also not precise enough. The smallest trial had only 5 people. No trial lasted longer than 28 weeks. Some treatments were tested in just one trial. A review can only be as good as the studies in it.

Source

Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

PubMed · PMID 41556478

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Essential tremor publications